StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$13.61−0.70 (-4.89%)

Close on Nov 13, 2026Market cap $200.42MP/E –Yield –

Korro Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Korro Bio's price to sales ratio was 89.0× on Nov 11, 2026, against 7.3× a year earlier. Over the last 4 years it ranged from 1.2× to 103.5×, with a median of 10.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202689.0×+78.7
2025Dec 31, 202510.2×+7.4
2022Jul 29, 20222.9×+0.0
2021Dec 31, 20212.8×−11.6
2020Dec 31, 202014.4×–

More Korro Bio figures

See a number that looks wrong?